Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
gemcitabine (gemzar) (1 trial)
abiraterone (zytiga) (1 trial)
cisplatin (platinol) (1 trial)
prednisone (meticorten) (1 trial)
sorafenib (nexavar) (1 trial)
sunitinib (sutent) (1 trial)
vinflunine (1 trial)
Carcinoma (Phase 3)
Carcinoma, Renal Cell (Phase 2)
Carcinoma, Transitional Cell (Phase 3)
Lung Neoplasms (Phase 2)
Neoplasm Metastasis (Phase 2)
Prostatic Neoplasms (Phase 2)
Urinary Bladder Neoplasms (Phase 3)
Trials (5 total)
Trial APIs (7 total)